CAR-Immunotherapy TRIALS

CAR-Immunotherapy package has 22 parameters for all trials registered internationally through 30 June 2018, including updates on their status. Cumulatively, 537 CAR-Immunotherapy trials have been registered worldwide. Purchasers will receive FREE UPDATES of new CAR-Immunotherapy trials twice a year for the next 3 years after purchase date.

  • Trial Data
    • Registration Year
    • Trial ID with link to trial on-line
    • Country
    • Phase
    • Status (updated as of end of June 2018)
  • Patient Data
    • Indication
    • Patient Age Groups
    • Target Enrollment
  • Cell Data
    • CAR Target
    • Cell Type
    • Cell Source
    • Donor Type
    • CAR Construct (costimulatory domain, vector, etc)
    • Cell Dose(s)
    • Mode of Administration (route and # doses)
    • Conditioning
    • Drug Support/Combos
  • Sponsor Data
    • Academia or Industry Funding
    • Sponsor Name
    • Study Acronym
  • Additional Information
    • Product Name
    • Notes - includes secondary trial IDs and reasons for termination

A graph of CAR-Immunotherapy trial numbers and phase versus time shows the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. There were 115 new CAR-Immunotherapy trials registered worldwide during the first half of 2018, and 41% of them were not registered in Comparing them to the 152 trials in 2017, we see there is 51% increase in number of trials versus half of last year, and the number of late phase trials is on track to double. CAR-T trials histogram thru 2018Q2

Public samples:
Sample-CAR-immunotherapy-trials.xlsx12.19 KB